PMGC Holdings Inc. - Common Stock (ELAB)

5.9900
+2.4300 (68.26%)
NASDAQ · Last Trade: Mar 31st, 6:49 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close3.560
Open3.950
Bid8.240
Ask8.260
Day's Range3.520 - 6.500
52 Week Range0.6613 - 77.89
Volume55,549,683
Market Cap-
PE Ratio (TTM)-88.09
EPS (TTM)-0.1
Dividend & YieldN/A (N/A)
1 Month Average Volume7,690,465

Chart

About PMGC Holdings Inc. - Common Stock (ELAB)

Elevai Labs, Inc. is a public company focused on advancing health technology through innovative artificial intelligence solutions. The company specializes in developing AI-driven platforms that enhance medical diagnostics, treatment planning, and patient care. By leveraging machine learning algorithms and data analysis, Elevai Labs aims to improve the accuracy and efficiency of healthcare delivery, ultimately transforming the way medical professionals make decisions and interact with patients. Their commitment to research and development positions them at the forefront of a rapidly evolving sector, addressing critical challenges in healthcare with cutting-edge technology. Read More

News & Press Releases

Top movers in Tuesday's after hours sessionchartmill.com
Via Chartmill · March 31, 2026
Spotlight Movers: APLS, VTIX, ELAB, ARTL Fuel Multi-Sector Momentum
A new wave of market-moving developments across biotech, defense technology, and emerging growth companies is putting Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), Virtuix Holdings, Inc. (NASDAQ: VTIX) , PMGC Holdings Inc. (NASDAQ: ELAB) , and Artelo Biosciences, Inc. (NASDAQ: ARTL) firmly on investor watchlists. Biotech M&A activity, defense-driven VR adoption, strategic capital deployment, and fresh funding catalysts are all contributing to rising investor interest across multiple high-growth sectors.
Via AB Newswire · March 31, 2026
On Tuesday, there are stocks with unusual volume. Let's take a look.chartmill.com
Via Chartmill · March 31, 2026
AGA Precision Systems Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products
NEWPORT BEACH, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- AGA Precision Systems LLC (“AGA”), a precision aerospace manufacturing company and wholly owned subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB), today announced the execution of a Long-Term agreement (“LTA”) with Turbo-Jet Products Co., Inc. (“Turbo-Jet Products”), a California-based aerospace and defense supplier.
By PMGC Holdings Inc. · Via GlobeNewswire · March 31, 2026
Which stocks are experiencing notable movement on Monday?chartmill.com
Via Chartmill · March 30, 2026
Curious about the most active stocks on Monday?chartmill.com
Via Chartmill · March 30, 2026
These stocks have an unusual volume in today's sessionchartmill.com
Via Chartmill · March 30, 2026
Here are the top movers in Monday's session.chartmill.com
Via Chartmill · March 30, 2026
Traders are paying attention to the gapping stocks in Monday's session.chartmill.com
Via Chartmill · March 30, 2026
Wondering what's happening in today's pre-market session?chartmill.com
Via Chartmill · March 30, 2026
PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024
NEWPORT BEACH, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“the Company,” “PMGC,” “we,” or “our”) today filed its Annual Report on Form 10-K (“Annual Report”) for the fiscal year ended December 31, 2025 (“FYE 2025”), with the U.S. Securities and Exchange Commission (“SEC”).
By PMGC Holdings Inc. · Via GlobeNewswire · March 30, 2026
Friday's after hours session: top gainers and loserschartmill.com
Via Chartmill · March 27, 2026
NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in Combination with GLP-1 Treatments
NEWPORT BEACH, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc.’s (NASDAQ: ELAB) (“PMGC,” “we,” or “our”) wholly owned subsidiary, NorthStrive Biosciences Inc. (“Northstrive Biosciences”), announced today a third amendment (“Amendment”) to its existing License Agreement with MOA Life Plus Co., Ltd., [KOSDAQ: 142760] a Korean biotechnology company (“MOA,” and such existing agreement, as amended, “License Agreement”) Northstrive Biosciences holds for EL-32 and EL-22.
By PMGC Holdings Inc. · Via GlobeNewswire · March 27, 2026
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Via Chartmill · March 25, 2026
Wednesday's session: top gainers and loserschartmill.com
Via Chartmill · March 25, 2026
There are notable gap-ups and gap-downs in today's session.chartmill.com
Via Chartmill · March 24, 2026
Which stocks are moving before the opening bell on Tuesday?chartmill.com
Via Chartmill · March 24, 2026
SVM Machining, Inc. Secures ITAR Registration, Enabling Entry into U.S. Defense Manufacturing Contracts
NEWPORT BEACH, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: PMGC) (“PMGC” or the “Company”), a diversified public holding company executing a targeted roll-up strategy in U.S.-based manufacturing, is pleased to announce that its wholly owned subsidiary, SVM Machining, Inc. dba Silicon Valley Manufacturing (“SVM”), has completed International Traffic in Arms Regulations (“ITAR”) registration and is in compliance with ITAR. The ITAR is administered by the U.S. State Department’s Directorate of Defense Trade Controls, which controls the export and import of defense articles and services.
By PMGC Holdings Inc. · Via GlobeNewswire · March 24, 2026
NorthStrive Biosciences Announces Launch of EL-32 Preclinical Study Evaluating Muscle Preservation in GLP-1 Weight Loss Therapy
NEWPORT BEACH, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq: ELAB) (“PMGC” or the “Company”) today announced the initiation of a preclinical study for EL-32, an engineered probiotic candidate being developed by its wholly owned subsidiary, NorthStrive Biosciences Inc. (“NorthStrive Biosciences”). The study is designed to evaluate EL-32’s potential to preserve lean muscle mass while promoting fat loss, both as a standalone therapy and in combination with GLP-1 weight loss treatments.
By PMGC Holdings Inc. · Via GlobeNewswire · March 10, 2026
Keep an eye on the top gainers and losers in Thursday's session.chartmill.com
Via Chartmill · March 5, 2026
Which stocks are experiencing notable movement on Thursday?chartmill.com
Via Chartmill · March 5, 2026
There are notable gap-ups and gap-downs in today's session.chartmill.com
Via Chartmill · March 5, 2026
Get insights into the top gainers and losers of Thursday's pre-market session.chartmill.com
Via Chartmill · March 5, 2026
PMGC Holdings Inc. Announces Anticipated Reverse Stock Split
NEWPORT BEACH, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”) today announced that it will effect a 1-for-6 reverse stock split (the “Split”) of its issued and outstanding and authorized common stock, par value $0.0001 per share (“Common Stock”), effective at 12:00 am, Eastern time, on March 10, 2026.
By PMGC Holdings Inc. · Via GlobeNewswire · March 4, 2026
This Heavily Sold Nano-Cap Skincare Stock Jumped 12% Pre-Market – What Happened?stocktwits.com
PMGC's unit, NorthStrive Biosciences, filed 10 new U.S. patent applications for EL-22 and EL-32 technologies in the animal health and agriculture markets.
Via Stocktwits · February 19, 2026